ICARES Medicus, Inc. Stock

Equities

6612

TW0006612005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
139.5 TWD +9.84% Intraday chart for ICARES Medicus, Inc. +2.20% +10.71%
Sales 2022 512M 15.75M Sales 2023 605M 18.63M Capitalization 4.93B 152M
Net income 2022 129M 3.97M Net income 2023 97M 2.98M EV / Sales 2022 4.6 x
Net cash position 2022 421M 12.94M Net cash position 2023 825M 25.39M EV / Sales 2023 6.79 x
P/E ratio 2022
21.4 x
P/E ratio 2023
45.2 x
Employees -
Yield 2022
1.23%
Yield 2023
0.16%
Free-Float 48.97%
More Fundamentals * Assessed data
Dynamic Chart
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ICARES Medicus, Inc.(TPEX:6612) added to S&P Global BMI Index CI
ICARES Medicus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
ICARES Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Icares Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Icares Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day+9.84%
1 week+2.20%
Current month+25.68%
1 month+24.55%
3 months+26.82%
6 months+2.20%
Current year+10.71%
More quotes
1 week
126.00
Extreme 126
139.50
1 month
106.00
Extreme 106
139.50
Current year
106.00
Extreme 106
139.50
1 year
106.00
Extreme 106
198.50
3 years
59.00
Extreme 59
198.50
5 years
47.00
Extreme 47
198.50
10 years
38.95
Extreme 38.95
198.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 11-07-13
President - 11-07-13
Director of Finance/CFO - 16-06-14
Members of the board TitleAgeSince
Director/Board Member - 14-04-20
Chief Executive Officer - 11-07-13
Chief Tech/Sci/R&D Officer - 15-02-12
More insiders
Date Price Change Volume
24-04-18 139.5 +9.84% 217,028
24-04-16 127 -1.93% 113,484
24-04-15 129.5 -2.63% 76,131
24-04-12 133 -2.56% 189,827
24-04-11 136.5 +5.81% 733,283

End-of-day quote Taipei Exchange, April 17, 2024

More quotes
Icares Medicus Inc is a Taiwan-based company mainly engaged in the authorization of high-end medical material surface treatment technology. The Company is also involved in the sale of surface treatment formulations and provision of customer surface treatment processing services, as well as the research and development, manufacture and sale of artificial lens and its implantation system. The Company's product revenue is mainly divided into three categories. The royalty income comes from the authorization of implantation/invasive high-end medical material surface treatment technology. The technical service income mainly includes implantation/invasive high-end medical surface treatment services, provision of medical coatings and foundry of artificial lens implantation systems. The sales of medical materials mainly include the sales of medical materials surface inspection equipment and other products. The Company distributes its products in domestic and overseas markets.
More about the company